DE60129863D1 - Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel - Google Patents

Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel

Info

Publication number
DE60129863D1
DE60129863D1 DE60129863T DE60129863T DE60129863D1 DE 60129863 D1 DE60129863 D1 DE 60129863D1 DE 60129863 T DE60129863 T DE 60129863T DE 60129863 T DE60129863 T DE 60129863T DE 60129863 D1 DE60129863 D1 DE 60129863D1
Authority
DE
Germany
Prior art keywords
hydroxy
substituted
azetidinones useful
hypocholesterolemic drugs
hypocholesterolemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60129863T
Other languages
English (en)
Other versions
DE60129863T2 (de
Inventor
Anima Ghosal
Shmuel Zbaida
Swapan K Chowdhury
Robert M Iannucci
Wenqing Feng
Kevin B Alton
James E Patrick
Harry R Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22973953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60129863(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE60129863D1 publication Critical patent/DE60129863D1/de
Publication of DE60129863T2 publication Critical patent/DE60129863T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60129863T 2000-12-20 2001-12-17 Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel Expired - Lifetime DE60129863T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25687500P 2000-12-20 2000-12-20
US256875P 2000-12-20

Publications (2)

Publication Number Publication Date
DE60129863D1 true DE60129863D1 (de) 2007-09-20
DE60129863T2 DE60129863T2 (de) 2008-04-30

Family

ID=22973953

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60129863T Expired - Lifetime DE60129863T2 (de) 2000-12-20 2001-12-17 Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel
DE60106489T Expired - Lifetime DE60106489T2 (de) 2000-12-20 2001-12-17 Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60106489T Expired - Lifetime DE60106489T2 (de) 2000-12-20 2001-12-17 Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel

Country Status (35)

Country Link
US (1) US20020137690A1 (de)
EP (1) EP1347987B1 (de)
JP (2) JP4351842B2 (de)
KR (1) KR100883461B1 (de)
CN (1) CN100475829C (de)
AR (1) AR035611A1 (de)
AT (2) ATE369334T1 (de)
AU (2) AU3104902A (de)
BR (1) BR0116212A (de)
CA (1) CA2432798C (de)
CY (1) CY1106912T1 (de)
CZ (1) CZ302193B6 (de)
DE (2) DE60129863T2 (de)
DK (2) DK1593670T3 (de)
EC (1) ECSP034659A (de)
ES (2) ES2287826T3 (de)
GE (1) GEP20053548B (de)
HK (2) HK1056735A1 (de)
HU (1) HUP0302269A3 (de)
IL (1) IL155771A0 (de)
MA (1) MA26975A1 (de)
MX (1) MXPA03005671A (de)
MY (1) MY129148A (de)
NO (2) NO326981B1 (de)
NZ (1) NZ525722A (de)
PE (1) PE20020718A1 (de)
PL (1) PL208242B1 (de)
PT (2) PT1347987E (de)
RU (1) RU2297422C2 (de)
SI (2) SI1347987T1 (de)
SK (1) SK286703B6 (de)
TR (1) TR200402758T4 (de)
TW (1) TWI316942B (de)
WO (1) WO2002050090A1 (de)
ZA (1) ZA200303694B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60206365T2 (de) 2001-03-28 2006-07-06 Schering Corporation, Kenilworth Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten
GB0215579D0 (en) * 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
JP2005015434A (ja) * 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (de) * 2003-10-07 2005-04-13 Lipideon Biotechnology AG Neue hypocholesterolemische Verbindungen
EP1918000A2 (de) 2003-11-05 2008-05-07 Schering Corporation Verbindungen aus lipidverändernden Wirkstoffen und substituierten Azetidinonen und Behandlungen für Gefäßzustände
US7871998B2 (en) * 2003-12-23 2011-01-18 Astrazeneca Ab Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
WO2005062824A2 (en) 2003-12-23 2005-07-14 Merck & Co., Inc. Anti-hypercholesterolemic compounds
GB0329778D0 (en) * 2003-12-23 2004-01-28 Astrazeneca Ab Chemical compounds
EP1807070A1 (de) * 2004-09-29 2007-07-18 Schering Corporation Kombinationen aus substituierten azetidinonen und cb1-antagonisten
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
AR054482A1 (es) * 2005-06-22 2007-06-27 Astrazeneca Ab Derivados de azetidinona para el tratamiento de hiperlipidemias
SA06270191B1 (ar) * 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
EP1849459A1 (de) * 2006-03-06 2007-10-31 Teva Pharmaceutical Industries Ltd. Ezetimibzusammensetzungen
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
RU2492175C2 (ru) * 2007-04-02 2013-09-10 Теракос, Инк. Бензиловые производные гликозидов и способы их применения
US20110243940A1 (en) 2008-12-16 2011-10-06 Schering Corporation Bicyclic pyranone derivatives and methods of use thereof
US20110245209A1 (en) 2008-12-16 2011-10-06 Schering Corporation Pyridopyrimidine derivatives and methods of use thereof
EP2396339B1 (de) * 2009-02-11 2014-07-02 Dow AgroSciences LLC Pestizidzusammensetzungen
WO2010100255A1 (en) 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Pharmaceutical hypocholesterolemic compositions
WO2010113175A2 (en) 2009-04-01 2010-10-07 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
KR101102749B1 (ko) * 2009-11-30 2012-01-05 최길용 곱셈 학습기
KR20150079373A (ko) 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
CN105055404B (zh) * 2015-08-19 2017-07-18 四川大学 Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5627176A (en) * 1994-03-25 1997-05-06 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
ATE219495T1 (de) * 1995-10-31 2002-07-15 Schering Corp Zuckersubstituierte 2-azetidinone, verwendbar als hypocholesterdenische arzneimittel
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
AUPQ342599A0 (en) * 1999-10-14 1999-11-04 University Of Melbourne, The Conjugates and uses thereof

Also Published As

Publication number Publication date
ES2230385T3 (es) 2005-05-01
ATE369334T1 (de) 2007-08-15
SK286703B6 (sk) 2009-03-05
AR035611A1 (es) 2004-06-16
DE60106489D1 (de) 2004-11-18
WO2002050090A1 (en) 2002-06-27
ES2287826T3 (es) 2007-12-16
SI1347987T1 (en) 2005-02-28
CZ20031674A3 (cs) 2003-10-15
PE20020718A1 (es) 2002-08-09
DK1593670T3 (da) 2007-11-05
NZ525722A (en) 2004-11-26
NO326981B1 (no) 2009-03-30
ECSP034659A (es) 2003-07-25
BR0116212A (pt) 2003-12-30
AU3104902A (en) 2002-07-01
NO20083737L (no) 2003-08-19
RU2003122520A (ru) 2005-02-27
KR20030063414A (ko) 2003-07-28
EP1347987B1 (de) 2004-10-13
JP4351842B2 (ja) 2009-10-28
SI1593670T1 (sl) 2007-12-31
DE60129863T2 (de) 2008-04-30
MY129148A (en) 2007-03-30
DE60106489T2 (de) 2005-10-13
HK1084945A1 (en) 2006-08-11
AU2002231049B2 (en) 2006-07-20
PL363237A1 (en) 2004-11-15
DK1347987T3 (da) 2005-01-31
CZ302193B6 (cs) 2010-12-08
RU2297422C2 (ru) 2007-04-20
JP2004516299A (ja) 2004-06-03
CN100475829C (zh) 2009-04-08
CN1483039A (zh) 2004-03-17
CA2432798C (en) 2007-02-27
IL155771A0 (en) 2003-12-23
KR100883461B1 (ko) 2009-02-16
HUP0302269A2 (hu) 2003-10-28
HK1056735A1 (en) 2004-02-27
WO2002050090A8 (en) 2004-04-15
GEP20053548B (en) 2005-06-27
PT1347987E (pt) 2005-01-31
CA2432798A1 (en) 2002-06-27
PL208242B1 (pl) 2011-04-29
MXPA03005671A (es) 2003-10-06
ZA200303694B (en) 2004-08-13
TR200402758T4 (tr) 2004-11-22
JP2009132745A (ja) 2009-06-18
CY1106912T1 (el) 2012-09-26
ATE279425T1 (de) 2004-10-15
US20020137690A1 (en) 2002-09-26
MA26975A1 (fr) 2004-12-20
PT1593670E (pt) 2007-11-08
TWI316942B (en) 2009-11-11
SK7702003A3 (en) 2003-10-07
NO20032806L (no) 2003-08-19
EP1347987A1 (de) 2003-10-01
NO20032806D0 (no) 2003-06-19
HUP0302269A3 (en) 2009-08-28

Similar Documents

Publication Publication Date Title
DE60129863D1 (de) Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel
HUP0303526A3 (en) Enantioselective synthesis of azetidinone intermediate compounds
AU2002231049A1 (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
NO20032194D0 (no) Vibrasjonssikt
ATE397928T1 (de) Glukokinase beeinflussende verbindungen
DK1226422T3 (da) Overflade-forstærkede spektroskopi-aktive nano-partikler
ATE299875T1 (de) Benzoamid-piperidin verbindungen als substanz p- antagonisten
DE60106039D1 (de) Schwingsieb
NO20032236L (no) Laktamforbindelse
HK1070840A1 (en) Pharmaceutical compositions based on azetidine derivatives
ATE362919T1 (de) Lactamverbindungen
ES1050610Y (es) Tornillo de seguridad.
ATE309239T1 (de) Aminopyrrol verbindungen als entzündungshemmende wirkstoffe
AT500080B8 (de) Trichterschirm
NO20025598D0 (no) Svingdör
FR2810688B1 (fr) Garde-corps notamment pour fenetres aux balcons
FI20000935A (fi) Ruuvirakenne
ES1048560Y (es) Pantalan de hormigon
FR2816348B1 (fr) Perfectionnement aux portes sectionnelles
IT250271Y1 (it) Cerniera per pannelli
AU2002331763A1 (en) Zonisamide intermediate and synthesis
PT102525B (pt) Bi-retentor de portas
DE29904123U1 (de) Variabel aufstellbarer Sichtschutz
ATA9272000A (de) Revisionstür
PL340313A1 (en) Self-supporting gate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition